Invitrogen™ Human LAIR1 ELISA Kit

Ref.: BL-RE-093060Manufacturer ref.: EH291RB 96 tests
€734.00 excl. VAT

Human LAIR1 quantitates human LAIR1 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human LAIR1.

Accession number
5133400O11Rik; BB115266; CD305; D7Bwg0421e; variable, heavy chain region of immunoglobulin; Lair1; LAIR-1; leukocyte-like receptor 1; leukocyte-like receptor 1; leukocyte-like receptor 1; leukocyte-like receptor 1; leukocyte-like receptor 1; rLAIR1
Dose range
0.6 to 130 ng/ml
Sensitivity of the dosage
0.6 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Human LAIR1 quantitates human LAIR1 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human LAIR1.

Human LAIR1 quantitates human LAIR1 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human LAIR1.

LAIR1 (CD305) works as an inhibitory receptor that plays a negative regulating role that is constitutive to the cytolytic function of natural killer cells (NK), B cells and T cells. Tyrus phosphorylation activation results in the recruitment and activation of PTPN6 and PTPN11 phosphatases. It also reduces the increase in intracellular calcium caused by the ligature of B-cell receptors. It can also act as an inhibitor independently of SH2-containing phosphatases. Modules the production of cytokine in CD4+ T cells, the production of IL2, and d的IFNG regulated downwards, while inducing secretion of the transformant beta growth factor. Also lowers the production of IgG and d-IgE in B cells, as well as secretion of IL8, IL10 and TNF. Inhibits proliferation and induces apoptosis in myeloid leukemic cell lines and prevents nuclear translocation of the NF-kappa-B p65/RELA subunit and phosphorylation of the I-kappa-B alpha/CHUK in these cells. Inhibits differentiation of precursors from peripheral blood to dendritic cells.

Sensitivity

Sensitivity of dosage: 0.6 ng/ml.

Measurement range

Dose range: 0.6 to 130 ng/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Target

Target: LAIR1 (CD305).

Samples

Type of sample: Plasma, Serum, Surnatant (surnatant volume, 50 µl; Serum, 50 µl; Plasma, 50 µl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17174583
Specifications
Accession number5133400O11Rik; BB115266; CD305; D7Bwg0421e; variable, heavy chain region of immunoglobulin; Lair1; LAIR-1; receptor similar to l-immunoglobulin associated with leukocytes 1; receptor similar to l-Ig associated with leukocytes 1; receptor similar to l-Ig associated with leukocytes 1; rece
Dose range0.6 to 130 ng/ml
Sensitivity of the dosage0.6 ng/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)Q6GTX8
Gene symbol(s)LAIR1
Coefficient of inter-dose variation<12%
Coefficient of intra-dose variation<10%
Contents of kits96 pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity96 tests
Regulatory statusUse exclusively for research
TargetLAIR1 (CD305)
Test time1 h 20 min
Physical characteristics
Volume of sampleSupernatant, 50 µl; Serum, 50 µl; Plasma, 50 µl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EH291RB
Country of originUnited States
HS customs code3002 12 00 00
A question or a specific configuration?
Contact us for a quote.